Shinji Toki

Inhibition of SUMOylation promotes remyelination and reduces IL-17 mediated autoimmune inflammation: Novel approach toward treatment of inflammatory CNS demyelinating disease

Å. Ljunggren-Rose, Pranathi Matta, Subramaniam Sriram, 2023, Journal of Neuroimmunology.